Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423340 · ClinicalTrials.gov registry record · NA
Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
NCT05423340 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 163 participants.
The verdict
NCT05423340, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
Study Summary
This is a randomized, parallel-group open-label trial to evaluate respiratory symptoms in ENDS users switching from banned flavors to a non-banned flavor (tobacco) or 'tobacco free' nicotine pouches.
Interventions
- OTHER E-cigarette Flavor
- OTHER Tobacco Free Nicotine Pouch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2022-06-12 |
| Est. Completion | 2024-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05423340
The ClinicalTrials.gov registry entry for NCT05423340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which E-cigarette Flavor is the first listed.
NCT05423340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05423340 about?
NCT05423340 is a clinical study titled "Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems". This is a randomized, parallel-group open-label trial to evaluate respiratory symptoms in ENDS users switching from banned flavors to a non-banned flavor (tobacco) or 'tobacco free' nicotine pouches.
What is the current status of trial NCT05423340?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2022-06-12. Estimated completion is 2024-10-03.
What interventions are being tested in trial NCT05423340?
The interventions under investigation include: E-cigarette Flavor (OTHER), Tobacco Free Nicotine Pouch (OTHER).
Who is sponsoring clinical trial NCT05423340?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.